Medical Properties Trust, Inc. Reports Fourth Quarter and Full-Year Results

Rhea-AI Summary

Medical Properties Trust (MPW) reported Q4 2020 net income of $0.20/share and full-year net income of $0.81/share. The company executed over $670 million in acquisitions during Q4, including a £800 million investment in UK behavioral health properties. NFFO increased by 21% in 2020, reaching $1.57/share. Key transactions included a $51 million sale of Olympia Medical Center and issuance of $1.3 billion in senior unsecured notes. The company expects 2021 net income to be $1.14-$1.18/share and NFFO at $1.72-$1.76/share. A conference call is scheduled for February 4, 2021.

Positive

• NFFO increased by 21% in 2020, reaching $1.57/share.
• Executed acquisitions totaling nearly $670 million in Q4 2020.
• Closed an £800 million investment in UK behavioral health properties.
• Expected 2021 net income is projected between $1.14-$1.18/share.

Negative

• Q4 2020 net income decreased from $0.26/share to $0.20/share year-over-year.
• Full-year 2020 net income decreased from $0.87/share to $0.81/share compared to 2019.

Medical Properties Trust, Inc. (the “Company” or “MPT”) (NYSE: MPW) today announced financial and operating results for the fourth quarter and full-year ended December 31, 2020 as well as certain events occurring subsequent to quarter end.

• Net income of $0.20 and Normalized Funds from Operations (“NFFO”) of $0.41 for the 2020 fourth quarter and net income of $0.81 and NFFO of $1.57 for the full-year 2020, all on a per diluted share basis;
• Closed in the fourth quarter on one inpatient rehabilitation (“IRF”) development agreement and six general acute and IRF acquisitions in the U.S., the U.K., Switzerland, and Colombia totaling nearly $670 million;
• Closed in mid-January on an £800 million real estate investment in behavioral health properties in the UK operated by Priory Group (“Priory”);
• In the first quarter of 2021 completed the sale of Olympia Medical Center to the UCLA Health System for proceeds of $51 million, recovering a loan balance of $25 million and other past due amounts at an overall expected gain exceeding $10 million;
• During and subsequent to the fourth quarter issued $1.3 billion in 3.5% senior unsecured notes due in 2031, redeemed $800 million of senior unsecured notes due in 2024 with a blended interest rate of 6%, raised $828 million in common equity, extended with improved pricing the existing $1.5 billion line of credit agreement, and arranged a $900 million interim credit facility.

“I am pleased that in spite of the pandemic, MPT grew NFFO per share by 21% in 2020 and is approaching $5 billion in investments closed since the end of 2019 in a manner both accretive to earnings and beneficial to operator and property diversity in an already strongly diverse portfolio,” said Edward K. Aldag, Jr., MPT’s Chairman, President, and Chief Executive Officer. “While not a surprise to MPT, the challenges of 2020 proved that hospitals are essential to global healthcare delivery and that our growth pipeline can sustain momentum under challenging circumstances.”

Mr. Aldag continued, “2021 is obviously off to a strong start on the investment front, and growth-related conversations with our operators are picking up as they emerge from 2020 with strong operations and significant liquidity.”

Included in the financial tables accompanying this press release is information about the Company’s assets and liabilities, net income, and reconciliations of net income to NFFO, all on a basis comparable to 2019 results, and reconciliations of total assets to pro forma total gross assets and total revenues to total adjusted revenues.

PORTFOLIO UPDATE

During the fourth quarter and thus far in 2021, MPT and its operators continued to execute on several accretive acquisitions despite the COVID-19 pandemic.

Throughout the fourth quarter, the Company closed on various investments in IRFs across the U.S. In late-November, MPT agreed to a roughly $48 million development in Stockton, CA with Ernest Health (“Ernest”) and also acquired an Ernest facility in Elgin, SC in late December for roughly $17 million. In addition, the Company acquired in December properties in El Paso, TX and the Louisville, KY market operated by Curahealth for a combined $58 million. These transactions were closed at a weighted average GAAP cap rate approximating 10%.

In addition to these U.S. rehabilitation facilities, MPT closed on the previously announced $130 million Colombian investment and three other transactions: (i) the Company purchased the 999-year ground lease at The Royal Marsden Private Care, a flagship facility located in London’s Cavendish Square and MPT’s first lease with the National Health Service (“NHS”), for £50 million; (ii) separately, MPT acquired Circle Reading Hospital, to be joined to MPT’s master lease agreement with Circle, in December for £85 million; and (iii) MPT increased its equity ownership and related investment in Infracore, the landlord entity of Swiss hospital operator Swiss Medical Network, for a total investment of approximately 207 million Swiss Francs. Terms of these investment agreements provide for long-term absolute net lease arrangements and investment returns well in-line with recently disclosed yields in the U.K. and Switzerland.

As discussed in more detail in the Company’s January 6, 2021 press release, MPT invested £800 million on January 19, 2021 in a sale-leaseback agreement of U.K. behavioral hospitals operated by Priory at an 8.6% GAAP cap rate. In addition, the Company extended a short-term £250 million loan to the purchaser of the operator, expected to be repaid by the end of the third quarter, and acquired a 9.9% equity interest in Priory. In relation to the deal, MPT utilized approximately £500 million of interim short-term financing at terms similar to those in its revolving line of credit agreement.

The Company has pro forma total gross assets of approximately $20.4 billion, including $15.1 billion in general acute care hospitals, $2.2 billion in inpatient rehabilitation hospitals, $1.7 billion in behavioral health facilities, $0.3 billion in long-term acute care hospitals, and $0.3 billion in freestanding emergency room and urgent care properties. MPT’s portfolio, pro forma for the transactions described herein, includes 431 properties representing roughly 43,000 licensed beds across the United States and in Germany, the United Kingdom, Switzerland, Italy, Spain, Portugal, Australia, and Colombia. The properties are leased to or mortgaged by 50 hospital operating companies. MPT continues to work with existing and new operators in the U.S. and abroad on numerous opportunities.

OPERATING RESULTS AND OUTLOOK

Net income for the fourth quarter and year ended December 31, 2020 was $110 million (or $0.20 per diluted share) and $431 million ($0.81 per diluted share), respectively, compared to $130 million (or $0.26 per diluted share) and $375 million ($0.87 per diluted share) in the year earlier periods.

NFFO for the fourth quarter and year ended December 31, 2020 was $220 million ($0.41 per diluted share) and $831 million ($1.57 per diluted share), respectively, compared to $171 million ($0.35 per diluted share) and $557 million ($1.30 per diluted share) in the year earlier periods.

Based on 2020 and 2021 year-to-date transactions, including the Priory sale-leaseback transaction, along with an assumed capital structure resulting in a net debt to EBITDA ratio between 5.0 and 6.0 times, MPT expects an annual run-rate of $1.14 to $1.18 per diluted share for net income and $1.72 to $1.76 per diluted share for NFFO.

These estimates do not include the effects, if any, of unexpected real estate operating costs, changes in accounting pronouncements, litigation costs, debt refinancing costs, acquisition costs, currency exchange rate movements, interest rate hedging activities, write-offs of straight-line rent or other non-recurring or unplanned transactions. Moreover, these estimates do not provide for the impact on MPT or its tenants and borrowers from the global COVID-19 pandemic. These estimates may change if the Company acquires or sells assets in amounts that are different from estimates, market interest rates change, debt is refinanced, new shares are issued, additional debt is incurred, other operating expenses vary, income from equity investments vary from expectations, or existing leases or loans do not perform in accordance with their terms.

CONFERENCE CALL AND WEBCAST

The Company has scheduled a conference call and webcast for Thursday, February 4, 2021 at 11:00 a.m. Eastern Time to present the Company’s financial and operating results for the quarter ended December 31, 2020. The dial-in numbers for the conference call are 844-535-3969 (U.S. and Canada) and 409-937-8903 (International); both numbers require passcode 6688297. The conference call will also be available via webcast in the Investor Relations section of the Company’s website, www.medicalpropertiestrust.com.

A telephone and webcast replay of the call will be available beginning shortly after the call’s completion through February 18, 2021. Dial-in numbers for the replay are 855-859-2056 and 404-537-3406 for U.S./Canada and International callers, respectively. The replay passcode for all callers is 6688297.

The Company’s supplemental information package for the current period will also be available on the Company’s website in the Investor Relations section.

The Company uses, and intends to continue to use, the Investor Relations page of its website, which can be found at www.medicalpropertiestrust.com, as a means of disclosing material nonpublic information and of complying with its disclosure obligations under Regulation FD, including, without limitation, through the posting of investor presentations that may include material nonpublic information. Accordingly, investors should monitor the Investor Relations page, in addition to following our press releases, SEC filings, public conference calls, presentations and webcasts. The information contained on, or that may be accessed through, our website is not incorporated by reference into, and is not a part of, this document.

About Medical Properties Trust, Inc.

Medical Properties Trust, Inc. is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world’s largest owners of hospitals with 431 facilities and roughly 43,000 licensed beds in nine countries and across four continents on a pro forma basis. MPT’s financing model facilitates acquisitions and recapitalizations and allows operators of hospitals to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations. For more information, please visit the Company’s website at www.medicalpropertiestrust.com.

This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements can generally be identified by the use of forward-looking words such as “may”, “will”, “would”, “could”, “expect”, “intend”, “plan”, “estimate”, “target”, “anticipate”, “believe”, “objectives”, “outlook”, “guidance” or other similar words, and include statements regarding our strategies, objectives, future expansion and development activities, and expected financial performance. Forward-looking statements involve known and unknown risks and uncertainties that may cause our actual results or future events to differ materially from those expressed in or underlying such forward-looking statements, including, but not limited to: (i) the economic, political and social impact of, and uncertainty relating to, the COVID-19 pandemic, including governmental assistance to hospitals and healthcare providers, including certain of our tenants; (ii) the ability of our tenants, operators and borrowers to satisfy their obligations under their respective contractual arrangements with us, especially as a result of the adverse economic impact of the COVID-19 pandemic, and government regulation of hospitals and healthcare providers in connection with same (as further detailed in our Current Report on Form 8-K filed with the SEC on April 8, 2020); (iii) our expectations regarding annual run-rate net income and NFFO per share; (iv) our success in implementing our business strategy and our ability to identify, underwrite, finance, consummate and integrate acquisitions and investments; (v) the nature and extent of our current and future competition; (vi) macroeconomic conditions, such as a disruption of or lack of access to the capital markets or movements in currency exchange rates; (vii) our ability to obtain debt financing on attractive terms or at all, which may adversely impact our ability to pursue acquisition and development opportunities and pay down, refinance, restructure or extend our indebtedness as it becomes due; (viii) increases in our borrowing costs as a result of changes in interest rates and other factors, including the potential phasing out of LIBOR after 2021; (ix) international, national and local economic, real estate and other market conditions, which may negatively impact, among other things, the financial condition of our tenants, lenders and institutions that hold our cash balances, and may expose us to increased risks of default by these parties; (x) factors affecting the real estate industry generally or the healthcare real estate industry in particular; (xi) our ability to maintain our status as a REIT for federal and state income tax purposes; (xii) federal and state healthcare and other regulatory requirements, as well as those in the foreign jurisdictions where we own properties; (xiii) the value of our real estate assets, which may limit our ability to dispose of assets at attractive prices or obtain or maintain equity or debt financing secured by our properties or on an unsecured basis; (xiv) the ability of our tenants and operators to comply with applicable laws, rules and regulations in the operation of the our properties, to deliver high-quality services, to attract and retain qualified personnel and to attract patients; (xv) potential environmental contingencies and other liabilities; and (xvi) the closing of the Priory sale-leaseback transaction.

The risks described above are not exhaustive and additional factors could adversely affect our business and financial performance, including the risk factors discussed under the section captioned “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2019 and as updated in our quarterly reports on Form 10-Q. Forward-looking statements are inherently uncertain and actual performance or outcomes may vary materially from any forward-looking statements and the assumptions on which those statements are based. Readers are cautioned to not place undue reliance on forward-looking statements as predictions of future events. We disclaim any responsibility to update such forward-looking statements, which speak only as of the date on which they were made.

MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES
Consolidated Balance Sheets
(Amounts in thousands, except for per share data)				December 31, 2020				December 31, 2019
Assets				(Unaudited)				(A)
	Real estate assets
		Land, buildings and improvements, intangible lease assets, and other		$	12,078,927			$	8,102,754
		Investment in financing leases			2,010,922				2,060,302
		Mortgage loans			248,080				1,275,022
			Gross investment in real estate assets		14,337,929				11,438,078
			Accumulated depreciation and amortization		(833,529	)			(570,042	)
			Net investment in real estate assets		13,504,400				10,868,036
	Cash and cash equivalents				549,884				1,462,286
	Interest and rent receivables				46,208				31,357
	Straight-line rent receivables				490,462				334,231
	Equity investments				1,123,623				926,990
	Other loans				858,368				544,832
	Other assets				256,069				299,599
Total Assets				$	16,829,014			$	14,467,331
Liabilities and Equity
	Liabilities
		Debt, net		$	8,865,458			$	7,023,679
		Accounts payable and accrued expenses			438,750				291,489
		Deferred revenue			36,177				16,098
		Obligations to tenants and other lease liabilities			144,772				107,911
			Total Liabilities		9,485,157				7,439,177
	Equity
		Preferred stock, $0.001 par value. Authorized 10,000
			shares; no shares outstanding		-				-
		Common stock, $0.001 par value. Authorized 750,000 shares;
			issued and outstanding - 541,419 shares at December 31, 2020 and 517,522 shares at December 31, 2019		541				518
		Additional paid-in capital			7,461,503				7,008,199
		Retained (deficit) earnings			(71,411	)			83,012
		Accumulated other comprehensive loss			(51,324	)			(62,905	)
		Treasury shares, at cost			(777	)			(777	)
			Total Medical Properties Trust, Inc. Stockholders' Equity		7,338,532				7,028,047
		Non-controlling interests			5,325				107
			Total Equity		7,343,857				7,028,154
Total Liabilities and Equity				$	16,829,014			$	14,467,331
		(A) Financials have been derived from the prior year audited financial statements.

	MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES
	Consolidated Statements of Income
	(Unaudited)
(Amounts in thousands, except for per share data)			For the Three Months Ended								For the Twelve Months Ended
			December 31, 2020				December 31, 2019				December 31, 2020				December 31, 2019
Revenues
	Rent billed		$	203,034			$	130,310			$	741,311			$	474,151
	Straight-line rent			55,184				33,643				158,881				110,456
	Income from financing leases			49,081				52,364				206,550				119,617
	Interest and other income			26,507				40,121				142,496				149,973
		Total revenues		333,806				256,438				1,249,238				854,197
Expenses
	Interest			85,190				70,434				328,728				237,830
	Real estate depreciation and amortization			72,196				44,152				264,245				152,313
	Property-related			5,712				8,598				24,890				23,992
	General and administrative			34,542				27,402				131,663				96,411
		Total expenses		197,640				150,586				749,526				510,546
Other income (expense)
	(Loss) gain on sale of real estate			(130	)			41,498				(2,833	)			41,560
	Real estate impairment charges			-				(21,031	)			(19,006	)			(21,031	)
	Earnings from equity interests			5,154				4,416				20,417				16,051
	Debt refinancing and unutilized financing costs			(27,569	)			(1,233	)			(28,180	)			(6,106	)
	Other (including mark-to-market adjustments on equity securities)			2,717				1,152				(6,782	)			(345	)
		Total other income (expense)		(19,828	)			24,802				(36,384	)			30,129
	Income before income tax			116,338				130,654				463,328				373,780
		Income tax (expense) benefit		(6,232	)			(731	)			(31,056	)			2,621
	Net income			110,106				129,923				432,272				376,401
	Net income attributable to non-controlling interests			(222	)			(285	)			(822	)			(1,717	)
	Net income attributable to MPT common stockholders		$	109,884			$	129,638			$	431,450			$	374,684
	Earnings per common share - basic and diluted:
		Net income attributable to MPT common stockholders	$	0.20			$	0.26			$	0.81			$	0.87
		Weighted average shares outstanding - basic		537,003				493,593				529,239				427,075
		Weighted average shares outstanding - diluted		538,351				494,893				530,461				428,299
	Dividends declared per common share		$	0.27			$	0.26			$	1.08			$	1.02

	MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES
	Reconciliation of Net Income to Funds From Operations
	(Unaudited)
(Amounts in thousands, except for per share data)				For the Three Months Ended								For the Twelve Months Ended
				December 31, 2020				December 31, 2019				December 31, 2020				December 31, 2019
FFO information:
		Net income attributable to MPT common stockholders		$	109,884			$	129,638			$	431,450			$	374,684
		Participating securities' share in earnings			(719	)			(954	)			(2,105	)			(2,308	)
			Net income, less participating securities' share in earnings	$	109,165			$	128,684			$	429,345			$	372,376
		Depreciation and amortization			83,327				53,497				306,493				183,921
		Loss (gain) on sale of real estate			130				(41,498	)			2,833				(41,560	)
		Real estate impairment charges			-				21,031				19,006				21,031
			Funds from operations	$	192,622			$	161,714			$	757,677			$	535,768
		Write-off of straight-line rent and other			(683	)			12,943				26,415				22,447
		Non-cash fair value adjustments			612				(4,636	)			9,642				(6,908	)
		Tax rate change			(366	)			-				9,295				-
		Debt refinancing and unutilized financing costs			27,569				1,233				28,180				6,106
			Normalized funds from operations	$	219,754			$	171,254			$	831,209			$	557,413
		Share-based compensation			12,554				10,069				47,154				32,188
		Debt costs amortization			3,548				2,761				13,937				9,675
		Rent deferral, net			1,267				-				(11,393	)			-
		Straight-line rent revenue and other			(71,659	)			(48,836	)			(238,687	)			(145,598	)
			Adjusted funds from operations	$	165,464			$	135,248			$	642,220			$	453,678
Per diluted share data:
		Net income, less participating securities' share in earnings		$	0.20			$	0.26			$	0.81			$	0.87
		Depreciation and amortization			0.16				0.11				0.57				0.43
		Loss (gain) on sale of real estate			-				(0.08	)			0.01				(0.10	)
		Real estate impairment charges			-				0.04				0.04				0.05
			Funds from operations	$	0.36			$	0.33			$	1.43			$	1.25
		Write-off of straight-line rent and other			-				0.03				0.05				0.05
		Non-cash fair value adjustments			-				(0.01	)			0.02				(0.01	)
		Tax rate change			-				-				0.02				-
		Debt refinancing and unutilized financing costs			0.05				-				0.05				0.01
			Normalized funds from operations	$	0.41			$	0.35			$	1.57			$	1.30
		Share-based compensation			0.02				0.02				0.09				0.08
		Debt costs amortization			0.01				0.01				0.02				0.02
		Rent deferral, net			-				-				(0.02	)			-
		Straight-line rent revenue and other			(0.13	)			(0.11	)			(0.45	)			(0.34	)
			Adjusted funds from operations	$	0.31			$	0.27			$	1.21			$	1.06
Notes: (A) Certain line items above (such as depreciation and amortization) include our share of such income/expense from unconsolidated joint ventures. These amounts are included with the activity of all of our equity interests in the "Earnings from equity interests" line on the consolidated statements of income.   (B) Investors and analysts following the real estate industry utilize funds from operations, or FFO, as a supplemental performance measure. FFO, reflecting the assumption that real estate asset values rise or fall with market conditions, principally adjusts for the effects of GAAP depreciation and amortization of real estate assets, which assumes that the value of real estate diminishes predictably over time. We compute FFO in accordance with the definition provided by the National Association of Real Estate Investment Trusts, or NAREIT, which represents net income (loss) (computed in accordance with GAAP), excluding gains (losses) on sales of real estate and impairment charges on real estate assets, plus real estate depreciation and amortization and after adjustments for unconsolidated partnerships and joint ventures.   In addition to presenting FFO in accordance with the NAREIT definition, we also disclose normalized FFO, which adjusts FFO for items that relate to unanticipated or non-core events or activities or accounting changes that, if not noted, would make comparison to prior period results and market expectations less meaningful to investors and analysts. We believe that the use of FFO, combined with the required GAAP presentations, improves the understanding of our operating results among investors and the use of normalized FFO makes comparisons of our operating results with prior periods and other companies more meaningful. While FFO and normalized FFO are relevant and widely used supplemental measures of operating and financial performance of REITs, they should not be viewed as a substitute measure of our operating performance since the measures do not reflect either depreciation and amortization costs or the level of capital expenditures and leasing costs necessary to maintain the operating performance of our properties, which can be significant economic costs that could materially impact our results of operations. FFO and normalized FFO should not be considered an alternative to net income (loss) (computed in accordance with GAAP) as indicators of our results of operations or to cash flow from operating activities (computed in accordance with GAAP) as an indicator of our liquidity.   We calculate adjusted funds from operations, or AFFO, by subtracting from or adding to normalized FFO (i) non-cash revenue, (ii) non-cash share-based compensation expense, and (iii) amortization of deferred financing costs. AFFO is an operating measurement that we use to analyze our results of operations based on the receipt, rather than the accrual, of our rental revenue and on certain other adjustments. We believe that this is an important measurement because our leases generally have significant contractual escalations of base rents and therefore result in recognition of rental income that is not collected until future periods, and costs that are deferred or are non-cash charges. Our calculation of AFFO may not be comparable to AFFO or similarly titled measures reported by other REITs. AFFO should not be considered as an alternative to net income (calculated pursuant to GAAP) as an indicator of our results of operations or to cash flow from operating activities (calculated pursuant to GAAP) as an indicator of our liquidity.

MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES
Annual Run‐Rate Guidance Reconciliation
(Unaudited)
			Annual Run-Rate Guidance - Per Share(1)
			Low			High
Net income attributable to MPT common stockholders			$	1.14		$	1.18
Participating securities' share in earnings				-			-
	Net income, less participating securities' share in earnings		$	1.14		$	1.18
Depreciation and amortization				0.58			0.58
Funds from operations			$	1.72		$	1.76
Other adjustments				-			-
Normalized funds from operations			$	1.72		$	1.76
(1) The guidance is based on current expectations and actual results or future events may differ materially from those expressed in this table, which is a forward-looking statement within the meaning of the federal securities laws. Please refer to the forward-looking statement included in this press release and our filings with the Securities and Exchange Commission for a discussion of risk factors that affect our performance.

Pro Forma Total Gross Assets
(Unaudited)
(Amounts in thousands)				December 31, 2020				December 31, 2019
		Total Assets		$	16,829,014			$	14,467,331
		Add:
		Real estate commitments on new investments(1)			1,901,087				1,988,550
		Unfunded amounts on development deals and commenced
		capital improvement projects(2)			166,258				163,370
		Accumulated depreciation and amortization			833,529				570,042
		Incremental gross assets of our joint ventures(3)			1,287,077				563,911
		Proceeds from new debt and equity subsequent to period-end			1,479,961				927,990
		Less:
		Cash used for funding the transactions above(4)			(2,067,345	)			(2,151,920	)
		Pro Forma Total Gross Assets(5)		$	20,429,581			$	16,529,274
(1) The 2020 column reflects investments made in 2021, including the acquisition of 40 facilities in the United Kingdom on January 19, 2021. The 2019 column reflects the acquisition of 30 facilities in the United Kingdom on January 8, 2020. (2) Includes $65.5 million and $41.7 million of unfunded amounts on ongoing development projects and $100.8 million and $121.7 million of unfunded amounts on capital improvement projects and development projects that have commenced rent, as of December 31, 2020 and December 31, 2019, respectively. (3) Adjustment to reflect our share of our joint ventures' gross assets. (4) Includes cash available on-hand plus cash generated from activities subsequent to period-end including proceeds from new debt, equity or loan repayments. (5) Pro forma total gross assets is total assets before accumulated depreciation/amortization and assumes all real estate commitments on new investments and unfunded amounts on development deals and commenced capital improvement projects are fully funded using cash on hand (if available). We believe pro forma total gross assets is useful to investors as it provides a more current view of our portfolio and allows for a better understanding of our concentration levels as our commitments close and our other commitments are fully funded.

Adjusted Revenues
(Unaudited)
(Amounts in thousands)			For the Year Ended December 31, 2020
		Total revenues	$	1,249,238
		Revenue from real estate properties owned through
		joint venture arrangements		105,758
		Total adjusted revenues(1)	$	1,354,996
(1) Adjusted revenues are total revenues adjusted for our pro rata portion of similar revenues in our real estate joint venture arrangements. We believe adjusted revenue is useful to investors as it provides a more complete view of revenue across all of our investments and allows for better understanding of our revenue concentration.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20210204005625/en/

FAQ

What were Medical Properties Trust's Q4 2020 financial results?

Medical Properties Trust reported Q4 2020 net income of $0.20 per share and NFFO of $0.41 per share.

How much did Medical Properties Trust acquire in Q4 2020?

In Q4 2020, Medical Properties Trust executed acquisitions totaling nearly $670 million.

What is the expected NFFO for Medical Properties Trust in 2021?

Medical Properties Trust expects NFFO for 2021 to be between $1.72 and $1.76 per share.

What major investment did Medical Properties Trust close in January 2021?

In January 2021, Medical Properties Trust closed an £800 million investment in behavioral health properties in the UK.

When is the next conference call for Medical Properties Trust?

The next conference call for Medical Properties Trust is scheduled for February 4, 2021 at 11:00 a.m. Eastern Time.